IMR Press / CEOG / Volume 49 / Issue 3 / DOI: 10.31083/j.ceog.2021.01.5524corr
Open Access Correction
Correction: Demir et al. Retrospective analysis of pregnancy terminations and indications in a tertiary center. Clinical and Experimental Obstetrics & Gynecology. 2021; 48: 85–90
Show Less
1 Department of Obstetrics and Gynecology, Division of Perinatology, Dokuz Eylul University School of Medicine, 35340 Izmir, Turkey
2 Department of Medical Genetics, Dokuz Eylul University School of Medicine, 35340 Izmir, Turkey
*Correspondence: drsureyyademir@hotmail.com (Sureyya Saridas Demir)
Academic Editor: Michael H. Dahan
Clin. Exp. Obstet. Gynecol. 2022, 49(3), 65; https://doi.org/10.31083/j.ceog.2021.01.5524corr
Submitted: 28 December 2021 | Revised: 5 January 2022 | Accepted: 8 January 2022 | Published: 9 March 2022
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.

The authors wish to make the following corrections to this paper [1]:

(1) The authors would like to add the 3 scholars to the list of authorship. And the newly added authors is responsible for the collection data of the paper. The corrected author information is provide below:

Sureyya Saridas Demir1,*, Erkan Cağliyan1, Sabahattin Altunyurt1, Tufan Çankaya2, Elçin Bora2, Derya Erçal2

1Department of Obstetrics and Gynecology, Division of Perinatology, Dokuz Eylul University School of Medicine, 35340 Izmir, Turkey

2Department of Medical Genetics, Dokuz Eylul University School of Medicine, 35340 Izmir, Turkey

(2) The authors would like to clarify that Turner syndrome is equivalent to monosomy X(Turner syndrome = monosomy X), So the author made the following changes in the full text:

① Replace Table 2 with the table below.

Table 2.Distribution of indications of termination of pregnancy by age range.
Age Range 29 30–34 35–39 40 Total
Central nervous system anomalies 28 35 10 6 79
PPROM (< 23w) 21 11 6 4 42
Multiple fetal anomalies 8 11 4 4 27
Anhydramnios (without congenital anomalies) 7 10 3 1 21
Cardiovascular system anomalies 9 7 2 2 20
Genitourinary system anomalies 8 4 1 1 14
Musculoskeletal system anomalies 7 4 2 1 14
Cystic Hygroma 3 2 1 6
Hydrops Fetalis 2 2 1 5
Thoracic anomalies 1 1 2
Use of X group drugs (methotrexate etc.) during pregnancy 1 2 2 5
Maternal Advanced stage malignancies 1 1 2
Maternal Cardiovascular and Renal diseases 1 1
Maternal Congenital metabolic liver diseases 1 1
Maternal fetal infections 1 1
Trisomy 21 6 10 12 11 39
Trisomy 18 2 5 3 6 16
Triploidy 1 3 1 5
Turner syndrome 3 2 2 7
Trisomy 13 1 2 3
Triple X syndrome 1 1 2
Duchene muscular dystrophy 1 1
Fragile X syndrome 1 1
Di George syndrome 1 1
Partial trisomy 3 1 1
Partial 4p deletion 1 1
Partial trisomy 18 1 1
Total n (%) 111 (34.9 %) 116 (36.4%) 53 (16.6%) 38 (11.9%) 318
Note: PPROM, Preterm premature rupture of membrane.

② Replace Table 4 with the table below.

Table 4.Distribution of chromosomal anomalies among all indications.
Number of patients Percentage
Chromosomal disorders
Trisomy 21 39 12.3%
Trisomy 18 16 5%
Turner syndrome 7 2.2%
Triploidy 5 1.6%
Trisomy 13 3 0.9%
Triple X syndrome 2 0.6%
Duchenne muscular dystrophy 1 0.3%
Fragile X syndrome 1 0.3%
Di George syndrome 1 0.3%
Partial trisomy 3 1 0.3%
Partial 4p deletion 1 0.3%
Partial trisomy 18 1 0.3%
Total 78

③ The original “Turner syndrome in 1.3%” in the first line in the right column of the 87 page is replaced by “Turner syndrome in 2.2 %”.

(3) The authors would like to re-clarify the author’s contribution, the corrected author’s contribution are provided below:

SSD, EC, SA designed the article. SSD, TC, EB, DE collected the data SSD analyzed the data and wrote the article. All authors contributed to editorial changes to the article. All authors have read and approved the final version of the article before publication.

References
[1]
Demir SS, Cağliyan E, Altunyurt S. Retrospective analysis of pregnancy terminations and indications in a tertiary center. Clinical and Experimental Obstetrics & Gynecology. 2021; 48: 85–90
Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Share
Back to top